Insider · CIK 0001569064
Suvretta Capital Management, LLC
directorowner
Files at BNTC (Benitec Biopharma Inc.). First filing Nov 21, 2024, latest Dec 29, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
8 / 0
$36M bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BNTC: Benitec Biopharma Inc.
BNTCOct 9, 2026 · close 8.87
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 49Moderate | BNTCbuy Benitec Biopharma Inc. | $1.9M 144,223 shares | +2% | +34% from low-23% from high | |
| 42Moderate | BNTCbuy Benitec Biopharma Inc. | $539k 46,141 shares | +0% | +17% from low-32% from high | |
| 47Moderate | BNTCbuy Benitec Biopharma Inc. | $20M 1,481,481 shares | +17% | +34% from low-24% from high | |
| 31Weak | BNTCbuy Benitec Biopharma Inc. | $212k 16,497 shares | +0% | +60% from low-23% from high | |
| 47Moderate | BNTCbuy Benitec Biopharma Inc. | $12M 900,000 shares | +11% | +72% from low-17% from high | |
| 33Weak | BNTCbuy Benitec Biopharma Inc. | $527k 47,520 shares | +1% | - | |
| 31Weak | BNTCbuy Benitec Biopharma Inc. | $403k 42,000 shares | +1% | - | |
| 26Weak | BNTCbuy Benitec Biopharma Inc. | $417k 41,436 shares | +1% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 23, 2025 | BNTC Benitec Biopharma Inc. | POpen-market purchase Common stock, par value $0.0001 per shareindirect: See footnotes | +42,600 | $12.85 | $547k | 9,620,075 | Dec 29, 2025 |
| Dec 23, 2025 | BNTC Benitec Biopharma Inc. | POpen-market purchase Common stock, par value $0.0001 per shareindirect: See footnotes | +7,400 | $12.85 | $95k | 1,834,053 | Dec 29, 2025 |
| Dec 26, 2025 | BNTC Benitec Biopharma Inc. | POpen-market purchase Common stock, par value $0.0001 per shareindirect: See footnotes | +14,320 | $13.10 | $188k | 9,634,395 | Dec 29, 2025 |
| Dec 26, 2025 | BNTC Benitec Biopharma Inc. | POpen-market purchase Common stock, par value $0.0001 per shareindirect: See footnotes | +2,516 | $13.10 | $33k | 1,836,569 | Dec 29, 2025 |
| Dec 29, 2025 | BNTC Benitec Biopharma Inc. | POpen-market purchase Common stock, par value $0.0001 per shareindirect: See footnotes | +65,800 | $13.44 | $884k | 9,700,195 | Dec 29, 2025 |
| Dec 29, 2025 | BNTC Benitec Biopharma Inc. | POpen-market purchase Common stock, par value $0.0001 per shareindirect: See footnotes | +11,587 | $13.44 | $156k | 1,848,156 | Dec 29, 2025 |
| Dec 18, 2025 | BNTC Benitec Biopharma Inc. | POpen-market purchase Common stock, par value $0.0001 per shareindirect: See footnotes | +8,700 | $11.24 | $98k | 9,546,875 | Dec 22, 2025 |
| Dec 18, 2025 | BNTC Benitec Biopharma Inc. | POpen-market purchase Common stock, par value $0.0001 per shareindirect: See footnotes | +1,515 | $11.24 | $17k | 1,821,327 | Dec 22, 2025 |
| Dec 19, 2025 | BNTC Benitec Biopharma Inc. | POpen-market purchase Common stock, par value $0.0001 per shareindirect: See footnotes | +13,950 | $11.48 | $160k | 9,560,825 | Dec 22, 2025 |
| Dec 19, 2025 | BNTC Benitec Biopharma Inc. | POpen-market purchase Common stock, par value $0.0001 per shareindirect: See footnotes | +2,434 | $11.48 | $28k | 1,823,761 | Dec 22, 2025 |
| Dec 22, 2025 | BNTC Benitec Biopharma Inc. | POpen-market purchase Common stock, par value $0.0001 per shareindirect: See footnotes | +16,650 | $12.08 | $201k | 9,577,475 | Dec 22, 2025 |
| Dec 22, 2025 | BNTC Benitec Biopharma Inc. | POpen-market purchase Common stock, par value $0.0001 per shareindirect: See footnotes | +2,892 | $12.08 | $35k | 1,826,653 | Dec 22, 2025 |
| Nov 7, 2025 | BNTC Benitec Biopharma Inc. | POpen-market purchase Common stock, par value $0.0001 per shareindirect: See footnotes | +730,370 | $13.50 | $9.9M | 9,538,175 | Nov 10, 2025 |
| Nov 7, 2025 | BNTC Benitec Biopharma Inc. | POpen-market purchase Common stock, par value $0.0001 per shareindirect: See footnotes | +751,111 | $13.50 | $10M | 1,819,812 | Nov 10, 2025 |
| Mar 31, 2025 | BNTC Benitec Biopharma Inc. | POpen-market purchase Common stock, par value $0.0001 per shareindirect: See footnotes | +9,503 | $12.63 | $120k | 8,802,748 | Apr 2, 2025 |
| Mar 31, 2025 | BNTC Benitec Biopharma Inc. | POpen-market purchase Common stock, par value $0.0001 per shareindirect: See footnotes | +1,267 | $12.63 | $16k | 1,068,031 | Apr 2, 2025 |
| Mar 31, 2025 | BNTC Benitec Biopharma Inc. | POpen-market purchase Common stock, par value $0.0001 per shareindirect: See footnotes | +5,057 | $13.22 | $67k | 8,807,805 | Apr 2, 2025 |
| Mar 31, 2025 | BNTC Benitec Biopharma Inc. | POpen-market purchase Common stock, par value $0.0001 per shareindirect: See footnotes | +670 | $13.22 | $8,857 | 1,068,701 | Apr 2, 2025 |
| Mar 26, 2025 | BNTC Benitec Biopharma Inc. | POpen-market purchase Common stock, par value $0.0001 per shareindirect: See footnotes | +793,800 | $13.00 | $10M | 8,793,245 | Mar 28, 2025 |
| Mar 26, 2025 | BNTC Benitec Biopharma Inc. | POpen-market purchase Common stock, par value $0.0001 per shareindirect: See footnotes | +106,200 | $13.00 | $1.4M | 1,066,764 | Mar 28, 2025 |
| Dec 23, 2024 | BNTC Benitec Biopharma Inc. | POpen-market purchase Common stock, par value $0.0001 per shareindirect: See footnotes | +24,360 | $10.98 | $267k | 7,981,725 | Dec 26, 2024 |
| Dec 23, 2024 | BNTC Benitec Biopharma Inc. | POpen-market purchase Common stock, par value $0.0001 per shareindirect: See footnotes | +3,142 | $10.98 | $34k | 958,266 | Dec 26, 2024 |
| Dec 24, 2024 | BNTC Benitec Biopharma Inc. | POpen-market purchase Common stock, par value $0.0001 per shareindirect: See footnotes | +17,730 | $11.25 | $199k | 7,999,455 | Dec 26, 2024 |
| Dec 24, 2024 | BNTC Benitec Biopharma Inc. | POpen-market purchase Common stock, par value $0.0001 per shareindirect: See footnotes | +2,288 | $11.25 | $26k | 960,554 | Dec 26, 2024 |
| Dec 3, 2024 | BNTC Benitec Biopharma Inc. | POpen-market purchase Common stock, par value $0.0001 per shareindirect: See footnotes | +37,190 | $9.60 | $357k | 7,957,365 | Dec 5, 2024 |
| Dec 3, 2024 | BNTC Benitec Biopharma Inc. | POpen-market purchase Common stock, par value $0.0001 per shareindirect: See footnotes | +4,810 | $9.60 | $46k | 955,124 | Dec 5, 2024 |
| Nov 19, 2024 | BNTC Benitec Biopharma Inc. | POpen-market purchase Common stock, par value $0.0001 per shareindirect: See footnotes | +12,430 | $9.73 | $121k | 7,895,815 | Nov 21, 2024 |
| Nov 19, 2024 | BNTC Benitec Biopharma Inc. | POpen-market purchase Common stock, par value $0.0001 per shareindirect: See footnotes | +1,570 | $9.73 | $15k | 947,238 | Nov 21, 2024 |
| Nov 20, 2024 | BNTC Benitec Biopharma Inc. | POpen-market purchase Common stock, par value $0.0001 per shareindirect: See footnotes | +24,360 | $10.22 | $249k | 7,920,175 | Nov 21, 2024 |
| Nov 20, 2024 | BNTC Benitec Biopharma Inc. | POpen-market purchase Common stock, par value $0.0001 per shareindirect: See footnotes | +3,076 | $10.22 | $31k | 950,314 | Nov 21, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.